Form 4: Universal Health Services Director Sussman Exercises Options and Sells Shares
SEC Form 4
Director Elliot J. Sussman of Universal Health Services Inc. reports exercising stock options and selling shares on March 1, 2024.
Summary
- On March 1, 2024, Elliot J. Sussman, a director of Universal Health Services Inc. (UHS), engaged in multiple transactions involving Class B Common Stock.
- Sussman exercised options to purchase 5,000 shares at $67.69 and 2,500 shares at $138.8.
- He also disposed of 4,008 shares to cover tax obligations at a price of $171.095 per share.
- Additionally, Sussman sold 3,492 shares at an average price of $170.992, with prices ranging from $170.93 to $171.085.
- Following these transactions, Sussman directly owns 3,951 shares of Class B Common Stock.
- He also holds options to purchase 5,000 shares exercisable until March 17, 2025, and 7,500 shares exercisable until March 16, 2026.
Sentiment
Score: 5
Explanation: The sentiment is neutral. This is a standard Form 4 filing detailing stock option exercises and sales, which are common activities for company directors. There's no indication of unusual or concerning behavior.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a broader trend within the healthcare industry. However, monitoring insider activity can provide insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Comparing Sussman's transactions to those of other directors in similar healthcare companies would require analyzing their Form 4 filings.
- Generally, insider selling can be interpreted negatively if it's a large percentage of their holdings or if multiple insiders are selling simultaneously.
- However, option exercises and sales to cover taxes are common and don't always signal a lack of confidence in the company.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the scale is unlikely to be significant.
- Employees are unlikely to be directly affected by these transactions.
Key Dates
| Date | Description |
|---|---|
| 03/18/2021 | First vesting date for 5,000 share option grant. |
| 03/17/2022 | First vesting date for 2,500 share option grant. |
| 03/18/2022 | Second vesting date for 5,000 share option grant. |
| 03/17/2023 | Second vesting date for 2,500 share option grant. |
| 03/18/2023 | Third vesting date for 5,000 share option grant. |
| 03/01/2024 | Date of transactions: option exercise and share sales. |
| 03/04/2024 | Date of Form 4 filing. |
| 03/17/2024 | Third vesting date for 2,500 share option grant. |
| 03/18/2024 | Final vesting date for 5,000 share option grant. |
| 03/16/2026 | Expiration date for options to purchase 7,500 shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.